The risk factors for developing of chronic pulmonary aspergillosis in nontuberculous mycobacteria patients and clinical characteristics and outcomes in chronic pulmonary aspergillosis patients coinfected with nontuberculous mycobacteria

Medical Mycology

Volumn 54, Issue 2, 2016, Pages 120-127

  Takeda, Kazuaki ^a,b   Imamura, Yoshifumi ^a   Takazono, Takahiro ^a   Yoshida, Masataka ^a   Ide, Shotaro ^a   Hirano, Katsuji ^a   Tashiro, Masato ^a   Saijo, Tomomi ^a   Kosai, Kosuke ^b   Morinaga, Yoshitomo ^b   Nakamura, Shigeki ^c   Kurihara, Shintaro ^a   Tsukamoto, Misuzu ^a   Miyazaki, Taiga ^a   Tashiro, Takayoshi ^a   Kohno, Shigeru ^a   Yanagihara, Katsunori ^b   Izumikawa, Koichi ^a  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^b NAGASAKI UNIVERSITY HOSPITAL   (Japan)

^c NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

chronic pulmonary aspergillosis; nontuberculous mycobacteria; outcome; prognosis

Indexed keywords

AMIKACIN; AMPHOTERICIN B LIPID COMPLEX; CASPOFUNGIN; CILASTATIN PLUS IMIPENEM; CLARITHROMYCIN; ETHAMBUTOL; ISONIAZID; MICAFUNGIN; PREDNISOLONE; RIFABUTIN; RIFAMPICIN; STEROID; VORICONAZOLE;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; ATYPICAL MYCOBACTERIOSIS; ATYPICAL MYCOBACTERIUM; BACTERIAL PNEUMONIA; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC RESPIRATORY FAILURE; DIABETES MELLITUS; DRUG USE; FEMALE; HUMAN; ILEUS; INTERSTITIAL PNEUMONIA; LUNG ASPERGILLOSIS; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MIDDLE AGED; MIXED INFECTION; MYCOBACTERIUM ABSCESSUS; MYCOBACTERIUM AVIUM COMPLEX; MYCOBACTERIUM KANSASII; RISK FACTOR; STEROID THERAPY; SURVIVAL; SURVIVAL RATE; VERY ELDERLY; COINFECTION; COMPLICATION; JAPAN; MORTALITY; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; PATHOLOGY; PULMONARY ASPERGILLOSIS; RETROSPECTIVE STUDY; SURVIVAL ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; COINFECTION; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; PULMONARY ASPERGILLOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 84960351268     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.1093/mmy/myv093     Document Type: Article

References (15)

1. Denning DW, Riniotis K, Dobrashian R et al. Chronic cavitary and fibrosing pulmonary and pleural aspergillosis: case series, proposed nomenclature change, and review. Clin Infect Dis 2003; 37: S265-S280.
2. Binder RE, Falling LJ, Pugatch RD et al. Chronic necrotizing pulmonary aspergillosis: a discrete clinical entity. Medicine (Baltimore) 1982; 61: 109-124.
3. Nam HS, Jeon K, Um SW et al. Clinical characteristics and treatment outcomes of chronic necrotizing pulmonary aspergillosis: a review of 43 cases. Int J Infect Dis 2010; 14: e479-e482.
4. Ohba H, Miwa S, Shirai M et al. Clinical characteristics and prognosis of chronic pulmonary aspergillosis. Respir Med 2012; 106: 724-729.
5. Zoumot Z, Boutou AK, Gill SS et al. , Mycobacterium avium complex infection in non-cystic fibrosis bronchiectasis. Respirology 2014; 19: 714-722.
6. Ishikawa S, Yano S, Kadowaki T et al. Clinical analysis of non-tuberculous mycobacteriosis cases complicated with pulmonary aspergillosis. Kekkaku 2011; 86: 781-785 [in Japanese].
7. Fujiuchi S, Sakunami M, Yamamoto Y et al. Analysis of chronic necrotizing pulmonary aspergillosis (CNPA) cases complicated with non-tuberculous mycobacteriosis (NTM). Kekkaku 2008; 83: 573-575 [in Japanese].
8. Kobashi Y, Fukuda M, Yoshida K et al. Chronic necrotizing pulmonary aspergillosis as a complication of pulmonary Mycobacterium avium complex disease. Respirology 2006; 11: 809-813.
9. Hayashi M, Takayanagi N, Kanauchi T et al. Prognostic factors of 634 HIV-negative patients with Mycobacterium avium complex lung disease. Am J Respir Crit Care Med 2012; 185: 575-583.
10. Kim JS, Rhee Y, Kang SM et al. A case of endobronchial aspergilloma. Yonsei Med J 2000; 41: 422-425.
11. Griffith DE, Aksamit T, Brown-Elliott BA et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007; 175: 367-416.
12. Travis WD, Costabel U, Hansell DM et al. An official American Thoracic Society/ European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2013; 188: 733-748.
13. Stuck AE, Minder CE, Frey FJ. Risk of infectious complications in patients taking glucocorticosteroids. Rev Infect Dis 1989; 11: 954-963.
14. Kunst H, Wickremasinghe M, Wells A et al. Nontuberculous mycobacterial disease and Aspergillus-related lung disease in bronchiectasis. Eur Respir J 2006; 28: 352-357.
15. Garnacho-Montero J, Amaya-Villar R, Ortiz-Leyba C et al. Isolation of Aspergillus spp. from the respiratory tract in critically ill patients: risk factors, clinical presentation and outcome. Crit Care 2005; 9: R191-R199.